BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3493854)

  • 1. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).
    Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM
    Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.
    Kok PW; Leeuwenburg J; Tukei P; van Wezel AL; Kapsenberg JG; van Steenis G; Galazka A; Robertson SE; Robinson D
    Bull World Health Organ; 1992; 70(1):93-103. PubMed ID: 1568283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
    Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
    Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
    Kong J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment.
    Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS
    Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monovalent type 1 oral poliovirus vaccine in newborns.
    el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
    N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
    Su W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Rev Infect Dis; 1984; 6 Suppl 2():S431. PubMed ID: 6740087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
    Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
    Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.
    Deivanayagam N; Nedunchelian K; Ahamed SS; Rathnam SR
    Bull World Health Organ; 1993; 71(3-4):307-9. PubMed ID: 8324848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National programme for the control of poliomyelitis.
    Sokhey J
    Indian J Public Health; 1985; 29(3):168-74. PubMed ID: 3835134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.